0.3203
price down icon1.08%   -0.0035
 
loading
前日終値:
$0.3238
開ける:
$0.3326
24時間の取引高:
2.22M
Relative Volume:
1.06
時価総額:
$54.66M
収益:
-
当期純損益:
$-119.76M
株価収益率:
-0.2373
EPS:
-1.35
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
+6.77%
1か月 パフォーマンス:
-9.34%
6か月 パフォーマンス:
-60.70%
1年 パフォーマンス:
-93.14%
1日の値動き範囲:
Value
$0.319
$0.3362
1週間の範囲:
Value
$0.3063
$0.39
52週間の値動き範囲:
Value
$0.295
$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Name
名前
Applied Therapeutics Inc
Name
セクター
Healthcare (1175)
Name
電話
212-220-9226
Name
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Name
職員
36
Name
Twitter
@Applied_Tx
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
APLT's Discussions on Twitter

APLT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
APLT
Applied Therapeutics Inc
0.3203 54.66M 0 -119.76M -55.17M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.00 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.16 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.33 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.02 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.15 28.51B 3.81B -644.79M -669.77M -6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-23 ダウングレード William Blair Outperform → Mkt Perform
2024-12-02 ダウングレード UBS Buy → Neutral
2024-11-29 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-07-31 開始されました William Blair Outperform
2024-03-26 開始されました RBC Capital Mkts Outperform
2024-02-22 開始されました Leerink Partners Outperform
2022-01-04 ダウングレード Barclays Overweight → Equal Weight
2021-08-27 ダウングレード Goldman Neutral → Sell
2021-06-25 再開されました Goldman Neutral
2020-10-08 開始されました Truist Buy
2020-04-22 開始されました Goldman Buy
2020-02-27 開始されました Barclays Overweight
2019-06-10 開始されました Citigroup Buy
2019-06-10 開始されました Cowen Outperform
2019-06-10 開始されました Robert W. Baird Outperform
すべてを表示

Applied Therapeutics Inc (APLT) 最新ニュース

pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces New Chief Medical Officer - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

APLT Announces Key Executive Promotions | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments | APLT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics promotes two executives to leadership roles - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Applied Therapeutics Announces Key Leadership Appointments - GlobeNewswire

Jun 17, 2025
pulisher
Jun 13, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New Investment in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Purchases 64,316 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics Elects New Director at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Applied Therapeutics holds annual stockholders meeting - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Buys New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jun 11, 2025
pulisher
Jun 11, 2025

Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $6.10 - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Wellington Management Group LLP Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Shares Acquired by Millennium Management LLC - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Applied Therapeutics, Inc. (APLT) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 06, 2025

Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Boosts Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Class Action Filed Against Applied Therapeutics, Inc. (APLT)February 18, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. LawsuitAPLT - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

Shareholders of Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

Jun 03, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Grows Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 31, 2025
pulisher
May 31, 2025

Janus Henderson Group PLC Sells 10,505,737 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 31, 2025
pulisher
May 27, 2025

Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud - The Intercept

May 27, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Decreases Stake in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

May 26, 2025
pulisher
May 25, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 25, 2025
pulisher
May 25, 2025

Price T Rowe Associates Inc. MD Sells 986,108 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 25, 2025
pulisher
May 24, 2025

William Blair Brokers Increase Earnings Estimates for APLT - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Applied Therapeutics (NASDAQ:APLT) Upgraded by Wall Street Zen to "Sell" Rating - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Vestal Point Capital LP Acquires 10,355,000 Shares of Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat

May 24, 2025
pulisher
May 24, 2025

Applied Therapeutics (NASDAQ:APLT) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025
pulisher
May 23, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

May 23, 2025
pulisher
May 23, 2025

Applied Therapeutics Inc (APLT): An Important Analyst Insights - Stocksregister

May 23, 2025
pulisher
May 22, 2025

Applied Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights – APLT - ACCESS Newswire

May 22, 2025
pulisher
May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug - MSN

May 19, 2025
pulisher
May 19, 2025

Applied Therapeutics’ Rare Disease Treatment Flunks in Late-Stage Trial - NewsBreak: Local News & Alerts

May 19, 2025
pulisher
May 19, 2025

New top-line data from Phase II/III trial of govorestat in CMT-SORD - The Pharma Letter

May 19, 2025
pulisher
May 19, 2025

Retail Traders Cheer Applied Therapeutics Data On Rare Nerve Disease Drug By Stocktwits - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and - GuruFocus

May 19, 2025
pulisher
May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripher - GuruFocus

May 18, 2025
pulisher
May 18, 2025

APLT Shares Results from INSPIRE Trial on Govorestat at Peripheral Nerve Society Meeting | APLT Stock News - GuruFocus

May 18, 2025
pulisher
May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - The Manila Times

May 18, 2025
pulisher
May 18, 2025

Applied Therapeutics Presents Full 12-Month Clinical - GlobeNewswire

May 18, 2025
pulisher
May 18, 2025

Breakthrough in CMT Treatment: New Clinical Data Shows First-Ever Disease Progression Slowing in 24-Month Study - Stock Titan

May 18, 2025
pulisher
May 18, 2025

Here's Why Amazon Is a Brilliant Buy Now (Hint: It's Not E-Commerce) - The Globe and Mail

May 18, 2025
pulisher
May 18, 2025

Massive News for Apple Stock Investors! - The Globe and Mail

May 18, 2025

Applied Therapeutics Inc (APLT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Applied Therapeutics Inc (APLT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Funtleyder Leslie D.
See Remarks
Mar 04 '25
Sale
0.44
14,502
6,381
390,459
Chinoporos Constantine
See Remarks
Mar 04 '25
Sale
0.44
447
197
271,436
Funtleyder Leslie D.
See Remarks
Feb 06 '25
Sale
0.61
22,950
14,000
404,961
Perfetti Riccardo
Chief Medical Officer
Feb 06 '25
Sale
0.61
86,078
52,508
900,775
Chinoporos Constantine
See Remarks
Feb 06 '25
Sale
0.61
28,117
17,151
271,883
Funtleyder Leslie D.
Chief Financial Officer
Aug 22 '24
Sale
5.83
13,530
78,880
277,911
Perfetti Riccardo
Chief Medical Officer
Aug 22 '24
Sale
5.83
22,681
132,230
986,853
Shendelman Shoshana
President and CEO
Aug 13 '24
Sale
6.18
357,423
2,208,874
4,810,430
Shendelman Shoshana
President and CEO
Aug 12 '24
Sale
5.98
300,000
1,794,000
5,167,853
Shendelman Shoshana
President and CEO
Aug 14 '24
Sale
5.93
119,591
709,175
4,690,839
$20.59
price up icon 0.39%
$35.94
price up icon 0.13%
$21.11
price up icon 2.33%
$100.28
price up icon 0.73%
$106.37
price down icon 0.26%
biotechnology ONC
$241.30
price up icon 0.24%
大文字化:     |  ボリューム (24 時間):